Tuesday, June 14, 2011 4:40:43 PM
I attended, too. Will Edwards, the PAI representative, also demanded that MNTA should start returning cash to stockholders. Frankly, I was surprised that a supposedly sophisticated investor would be asking such a young company facing the potential $60b untapped market for FOBs, and having only just tapped a steady source of income, start depleting its accumulated cash so early in the game. The other stockholders present appeared to disagree with him.
Wheeler also made the point in response to a questioner (I think it was the guy in the green shirt) that he was still actively pursuing big pharma partners for developing the FOBs, and expressly did not wish to spend MNTA's cash in order to build an infrastructure to do it in house as long as he faced the possible "cliff" of another enoxaparin generic appearing on the scene and cutting off the cash.
The stockholders' questions seemed much more interesting than the typical analysts' questions on conference calls.
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
